Want to see SRXH full AI Analyst Report?
SRXH Stock Chart & Stats
$0.24
--
Market closed
$0.24
--
Day’s Range― - ―
52-Week Range$0.96 - $46.74
Previous CloseN/A
VolumeN/A
Average Volume (3M)3.82M
Market Cap
$19.38M
Enterprise Value$8.86M
Total Cash (Recent Filing)$26.07M
Total Debt (Recent Filing)$22.62M
Price to Earnings (P/E)―
Beta0.23
Next Earnings
May 20, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-123.08
Shares Outstanding9,837,579
10 Day Avg. Volume8,522,182
30 Day Avg. Volume3,819,440
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)22.88
Price to Sales (P/S)1.43
P/FCF Ratio-1.14
Enterprise Value/Market Cap0.46
Enterprise Value/Revenue-0.29
Enterprise Value/Gross Profit-1.08
Enterprise Value/Ebitda-0.51
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.32
Revenue Forecast (FY)$95.00M
Bulls Say, Bears Say
Bulls Say
Strategic Pivot To AI And Digital-asset TreasuryThe merger and rebrand to an AI-driven treasury/asset-allocation platform diversifies revenue beyond specialty pharmacy into recurring investment-management and treasury services. If execution succeeds, this creates new fee and investment-return streams that reduce reliance on volatile dispensing volumes.
Demonstrated Capital-return CapabilityManagement has realized and monetized asset gains (SpaceX exposure) to return capital and authorized a sizable buyback, indicating access to investable assets and disciplined allocation. Sustainable if the new treasury strategy continues to generate positive returns without draining operations.
Positive Unit Economics On DispensingA positive gross margin (~23%) implies the core specialty pharmacy dispensing economics remain viable at the unit level. With cost structure rationalization or restored volume, positive unit margins could support a recovery path toward operating leverage and eventual profitability.
Bears Say
Severe Revenue Decline And Scale LossAn ~88% revenue collapse destroys core scale, undermining negotiating leverage with payors and manufacturers and impairing fixed-cost absorption. Restoring sustainable top-line requires rebuilding prescription volume or establishing substantive new revenue channels—both lengthy, execution-sensitive efforts.
Persistent Cash Burn And Negative Free Cash FlowRepeated negative operating and free cash flows indicate the business is not self-funding and consumes liquidity. Ongoing cash burn elevates refinancing and solvency risk, may force asset sales or dilutive financing, and constrains investment in operations or strategic initiatives over the medium term.
Thin Equity, Leverage And Capital-structure Dilution RiskVery thin equity relative to debt and historical episodes of negative equity limit balance-sheet flexibility. The recent issuance of large numbers of shares/warrants as part of the EMJ exchange increases dilution risk and complicates governance, making future financing and strategic moves more costly or dilutive.
SRx Health Solutions News
SRXH FAQ
What was Srx Health Solutions Inc.’s price range in the past 12 months?
Srx Health Solutions Inc. lowest stock price was $0.96 and its highest was $46.74 in the past 12 months.
What is Srx Health Solutions Inc.’s market cap?
Srx Health Solutions Inc.’s market cap is $19.38M.
When is Srx Health Solutions Inc.’s upcoming earnings report date?
Srx Health Solutions Inc.’s upcoming earnings report date is May 20, 2027 which is in 313 days.
How were Srx Health Solutions Inc.’s earnings last quarter?
Srx Health Solutions Inc. released its earnings results on May 14, 2026. The company reported -$1.28 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.28.
Is Srx Health Solutions Inc. overvalued?
According to Wall Street analysts Srx Health Solutions Inc.’s price is currently Overvalued.
Does Srx Health Solutions Inc. pay dividends?
Srx Health Solutions Inc. pays a N/A dividend of $0.05 which represents an annual dividend yield of N/A. See more information on Srx Health Solutions Inc. dividends here
What is Srx Health Solutions Inc.’s EPS estimate?
Srx Health Solutions Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Srx Health Solutions Inc. have?
Srx Health Solutions Inc. has 9,837,579 shares outstanding.
What happened to Srx Health Solutions Inc.’s price movement after its last earnings report?
Srx Health Solutions Inc. reported an EPS of -$1.28 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.42%.
Which hedge fund is a major shareholder of Srx Health Solutions Inc.?
Currently, no hedge funds are holding shares in SRXH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Srx Health Solutions Inc.
SRX Global Inc. develops artificial intelligence (AI)-powered solutions designed to improve decision-making, streamline operations, and strengthen risk management. The company is headquartered in Tampa, Florida.
Technical Analysis
Grifols SA
―
Scilex Holding Company
―
Organon
―
Citius Oncology
―
MIRA Pharmaceuticals, Inc.
―
Ownership Overview
16.62% Insiders
1.11% Mutual Funds
― Other Institutional Investors
82.27% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---